In vitro-in vivo extrapolation (IVIVE) analyses translating high-throughput screening (HTS) data to human relevance have been limited.
Mathematical model reveals role of nucleotide signaling in airway surface liquid homeostasis and its dysregulation in cystic fibrosis
Mucociliary clearance is composed of three components (i.e., mucin secretion, airway surface hydration, and ciliary-activity) which function coordinately to clear inhaled microbes and other foreign particles from airway surfaces.
DILIsym Services Inc., a Simulations Plus Company, Releases DILIsym® Version 6A
Significant update of liver safety program includes performance and capability enhancements
MembranePlus 2.0 Release Notes
Our Simulations Plus development team continues to work hard to make MembranePlus the most advanced and reliable simulation of drug absorption and metabolism in cell based assays in the world today.
In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation
We developed simulation and modeling methods to predict the in vivo pharmacokinetic profiles of acyclovir, following escalating oral doses of valacyclovir, in wildtype and Pept1knockout mice.
Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery
Self-emulsifying drug delivery systems (SEDDS) have been used to solubilize poorly water-soluble drugs to improve exposure in high-dose pharmacokinetic (PK) and toxicokinetic (TK) studies.
In silico prediction of skin metabolism and its implication in toxicity assessment
Skin, being the largest organ of the body, represents an important route of exposure, not only for the abundance of chemicals present in the environment, but also for...
The Use of In Vitro and In Silico Technologies for Predicting Human Pharmacology and Toxicology of Carfentanil
Carfentanil is an ultra-potent opioid of public health and chemical weapons defense concern.
Integrating in vitro, modeling, and in vivo approaches to investigate warfarin bioequivalence
We demonstrate the use of modeling and simulation to investigate bioequivalence concerns raised about generic warfarin products.
Identification and characterisation of a salt form of Danirixin with reduced pharmacokinetic variability in patient populations
The natural variability of gastric pH or gastric acid reducing medications can result in lower and more variable clinical pharmacokinetics for basic compounds in patient populations.
Oral product input to the GI tract: GIS an oral product performance technology
The patient receives a pharmaceutical product, not a drug.
Calcium Phosphate Particles as Pulmonary Delivery System for Interferon-α in Mice
Systemically administered interferons are rapidly cleared from the circulation thus requiring frequent dosing to maintain the therapeutic levels of circulating interferon.
Using Quantitative Systems Toxicology (QST) to Assess Drug Safety: The Experience of the DILIsimInitiative. ®
Drug-Induced Liver Injury (DILI) remains a major problem in drug development.
Simulation of in vitro Dissolution and Degradation of Orntide-loaded PLGA Microspheres
An in vitro dissolution model has been developed to describe the drug release from orntide-loaded PLGA microspheres.
Utility of Physiologically Based Pharmacokinetic Absorption Modeling to Predict the Impact of Salt-to-Base Conversion on Prasugrel HCl Product Bioequivalence in the Presence of Proton Pump Inhibitors
Prasugrel HCl may convert to prasugrel base during manufacturing or storage. It was reported that formulations with different ratios of salt to base were bioequivalent in healthy subjects...
Prediction of Intracellular Exposure Bridges the Gap Between Target- and Cell-Based Drug Discovery
Inadequate target exposure is a major cause of high attrition in drug discovery. Here, we show that a label-free method for quantifying the intracellular bioavailability (Fic) of drug molecules…
Simulations Plus Sets Date for 3rd Quarter 2017 Earnings Release and Conference Call
Conference Call to be on Monday, July 10, 2017, at 4:15 PM ET